100.00% -0.0001

Virpax Pharmaceuticals Inc (VRPX)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Virpax Pharmaceuticals Inc Stock (VRPX) Company Profile

Virpax Pharmaceuticals Inc

Healthcare (1104)

Biotechnology (617)

Nächster Verdiensttermin

Neueste SEC-Einreichungen

VRPX's Discussions on Twitter

Compare VRPX vs VRTX, REGN, ARGX, ALNY, RVMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
VRPX Virpax Pharmaceuticals Inc	0.00	0	0	-12.07M	-16.71M	-10.62
VRTX Vertex Pharmaceuticals Inc	451.63	114.63B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	609.94	63.95B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	877.72	54.58B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	278.09	37.13B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	162.99	34.65B	742.00K	-1.37B	-1.07B	-7.0731

Virpax Pharmaceuticals Inc Aktie (VRPX) Neueste Nachrichten

Finanzdaten der Virpax Pharmaceuticals Inc-Aktie (VRPX)

Virpax Pharmaceuticals Inc (VRPX)

Virpax Pharmaceuticals Inc Stock (VRPX) Company Profile

Compare VRPX vs VRTX, REGN, ARGX, ALNY, RVMD

Virpax Pharmaceuticals Inc Aktie (VRPX) Neueste Nachrichten

Top Players and Market Competition in the Non-Opioid Pain Patch Industry - openPR.com

VRPX Stock Plummets 95.5% in Pre-Market Trading on NASDAQ - Meyka

Virpax Pharmaceuticals, Inc. (VRPX) - Minichart

Virpax Pharmaceuticals (VRPX) Expected to Announce Earnings on Tuesday - Defense World

Comparing Virios Therapeutics (NASDAQ:VIRI) & Virpax Pharmaceuticals (NASDAQ:VRPX) - Defense World

VRPX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Petros Pharmaceuticals (NASDAQ:PTPI) versus Virpax Pharmaceuticals (NASDAQ:VRPX) Head-To-Head Contrast - Defense World

Revenue per share of Virpax Pharmaceuticals, Inc. – OTC:VRPX - TradingView

Virpax reports positive study results for pain management drug - MSN

Virpax Pharmaceuticals to conduct reverse stock split - Intellectia AI

Virpax Pharmaceuticals director resigns due to compliance - MSN

Virpax Pharmaceuticals Highlights Leadership Contributions at Clinical Trial Conference - MSN

EBITDA per share of Virpax Pharmaceuticals, Inc. – OTC:VRPX - TradingView — Track All Markets

Virpax Pharmaceuticals Inc. (VRPX) Stock Price | Live Quotes & Charts | EXPM - StocksToTrade

Tangible book value per share of Virpax Pharmaceuticals, Inc. – OTC:VRPX - TradingView — Track All Markets

CapEx per share of Virpax Pharmaceuticals, Inc. – OTC:VRPX - TradingView — Track All Markets

RTW Biotech invests USD5.9 million in Yarrow Bioscience funding round - marketscreener.com

Stocks advance as Nvidia earnings light up global markets - marketscreener.com

Wall Street opens higher as Nvidia test looms - marketscreener.com

Virpax Pharmaceuticals Advances Pain Management with Promising Probudur Study Results - MSN

Jones Expects Nasdaq to Climb Higher, Lower Rates - marketscreener.com

TNF Pharmaceuticals Regains Compliance With Nasdaq Listing Requirement - marketscreener.com

Vinay Shah Net WorthInsider Trades and Bio as of Apr 21, 2026 - Benzinga

Nasdaq Announces Delisting of Multiple Companies Including NKGen Biotech, Aquaron Acquisition Corp, and Others - Quiver Quantitative

Virpax and Nanomerics Enter Technology License Agreement for Developing A Product for PTSD Treatment - StatNano

ENSCW Stock Price, News & Analysis - Stock Titan

BTAX Stock Price, News & Analysis - Stock Titan

QBIO Stock Price, News & Analysis - Stock Titan

EVLO Stock Price, News & Analysis - Stock Titan

PXMD Stock Price, News & Analysis - Stock Titan

XSNX Stock Price, News & Analysis - Stock Titan

Virpax Pharmaceuticals stock plummets on Nasdaq delisting news - Investing.com

Virpax Pharmaceuticals enacts 1-for-25 reverse stock split - Investing.com

Virpax Reports on Progress of Envelta™ - Business Wire

Virpax Pharmaceuticals announces 1-for-25 reverse stock split By Investing.com - Investing.com UK

Virpax Looking to Use MET to Develop Intranasal COVID Vaccine - FinancialContent

Can Virpax's Nasal Pain Treatment Solve the Opioid Addiction Problem? - Stock Titan

Virpax Pharmaceuticals Applauds Successful Trial of Molecular Envelope Technology - MyChesCo

VRPX Soars On MET Results, COLL Projects 16%-19% Revenue Growth In 2025, RPID Gains Momentum - RTTNews

Military Breakthrough: New Pain Control Drug Shows 96-Hour Combat Effectiveness in Army Tests - Stock Titan

Virpax Pharmaceuticals appoints new independent director - MSN

Virpax Pharmaceuticals director resigns due to compliance By Investing.com - Investing.com Nigeria

Virpax's Matthew Barnes to Present at Outsourcing in Clinical Trials Conference - FinancialContent

Virpax Pharmaceuticals Closes of $6.0 Million Public Offering of Common Stock - citybiz

User - The Chronicle-Journal

Virpax Pharmaceuticals stock hits 52-week low at $0.29 - MSN

Virpax Pharmaceuticals granted Nasdaq listing extension - Investing.com

Virpax Pharmaceuticals names new board director - Investing.com

Virpax Pharmaceuticals lowers quorum requirement By Investing.com - Investing.com Nigeria

Capricor Therapeutics (CAPR) Stock Surges Amid Positive Analyst Ratings - GuruFocus

Spartan Capital Securities, LLC Serves as Sole Placement Agent in Virpax Pharmaceuticals, Inc.'s $5.0 Million Public Offering - The Manila Times

Finanzdaten der Virpax Pharmaceuticals Inc-Aktie (VRPX)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie VRPX